Literature DB >> 26898619

Small-cell lung cancer in never-smokers: A case series.

Ana Tavares e Castro1, Joana Clemente2, L Carvalho3, Sara Freitas2, Jessica Cemlyn-Jones2.   

Abstract

Small-cell lung cancer (SCLC) is closely correlated with smoking and only sporadic cases have been reported in non-smoking patients. Environmental tobacco smoke and/or occupational risk factors have been suggested as possible causes of lung cancer in this subset of patients. However, particularly in relation to SCLC there is not enough reliable information. All patients with lung cancer in follow-up for a period of three-months at the Pulmonology Unit of Coimbra University Hospital were retrospectively assessed. From a total of 303 patients, 35 had SCLC, 4 of which were never-smokers and their clinical cases are hereby presented. A detailed questionnaire was given to all patients, which excluded second-hand smoking or occupational hazards. They were all female with a mean age of 63.0 ± 15.7 years. The most frequent complaints were cough, dyspnoea, anorexia and significant weight loss. Diagnosis was obtained by transbronchial biopsies in all cases. Two patients had locally advanced disease and the other two had extensive-disease due to distant metastases. Treatment approaches included first-line chemotherapy with platin and etoposide duplet and partial remission was achieved in half the cases. All patients died; mean survival was 15.8 ± 3.8 months. Further studies are needed for a better understanding of the pathogenicity of non-smoking related SCLC and we hope that this case series with its meticulous exclusion of potential risk factors will be a useful contribution.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Never-smoker; Small-cell lung cancer; Women

Mesh:

Substances:

Year:  2016        PMID: 26898619     DOI: 10.1016/j.lungcan.2016.01.006

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  Characteristics and clinical outcomes of patients with nonsmoking small cell lung cancer in Korea.

Authors:  Hye Seon Kang; Jung Uk Lim; Chang Dong Yeo; Chan Kwon Park; Sang Haak Lee; Seung Joon Kim
Journal:  BMC Pulm Med       Date:  2022-05-18       Impact factor: 3.320

2.  Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.

Authors:  Anish Thomas; Idrees Mian; Camille Tlemsani; Lorinc Pongor; Nobuyuki Takahashi; Kathleen Maignan; Jeremy Snider; Gerald Li; Garrett Frampton; Siraj Ali; Sehyun Kim; Samantha Nichols; Vinodh Rajapakse; Udayan Guha; Elad Sharon; Junya Fujimoto; Cesar A Moran; Ignacio I Wistuba; Jun S Wei; Javed Khan; Eva Szabo; Aracelis Z Torres; Kenneth R Carson
Journal:  Chest       Date:  2020-05-26       Impact factor: 9.410

3.  High Biologically Effective Dose Radiotherapy for Brain Metastases May Improve Survival and Decrease Risk for Local Relapse Among Patients With Small-Cell Lung Cancer: A Propensity-Matching Analysis.

Authors:  Qing-Yang Zhuang; Jin-Luan Li; Fei-Fei Lin; Xi-Jin Lin; Huaqin -Lin; Youjia -Wang; Yaobin -Lin; Yun-Xia Huang; Xue-Qing Zhang; Li-Rui Tang; Jun-Xin Wu
Journal:  Cancer Control       Date:  2020 Apr-Jun       Impact factor: 3.302

4.  Weight loss might be an early clinical manifestation of undiagnosed cancer: a nation-based cohort study.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Biomedicine (Taipei)       Date:  2018-11-26

5.  Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer.

Authors:  Orgilmaa Regzedmaa; Ying Li; Yongwen Li; Hongbing Zhang; Jin Wang; Hao Gong; Yin Yuan; Weiting Li; Hongyu Liu; Jun Chen
Journal:  Onco Targets Ther       Date:  2019-11-21       Impact factor: 4.147

6.  Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer.

Authors:  Fei Li; Shu-Hua Zhang; Li-Min Pang
Journal:  Oncotarget       Date:  2017-07-31

7.  Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis.

Authors:  Kenan Zhou; Shishun Zhao; Wenlai Guo; Lei Ding
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

8.  Short-Term Efficacy of Different First-Line Chemotherapy Regimens for Advanced Non-Small Cell Lung Cancer: A Network Meta-Analysis.

Authors:  Bei-Bei Zhang; Weibo Zhu; Jun Tao; Yun Li; Chuan-Chong Du; Yun-Xia Chen; Yan-Dong Liu
Journal:  Clin Transl Sci       Date:  2020-02-27       Impact factor: 4.689

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.